Alirocumab cuts apheresis rates in familial hypercholesterolemia
Patients who have heterozygous familial hypercholesterolemia (HeFH), a condition that causes abnormally raised low-density lipoprotein cholesterol (LDL-C) levels and premature cardiovascular disease, can significantly reduce ...
Aug 29, 2016
0
0